Literature DB >> 15028948

Onset symptoms and tumor locations as prognostic factors of pancreatic cancer.

Ichiro Watanabe1, Satoshi Sasaki, Masaru Konishi, Toshio Nakagohri, Kazuto Inoue, Tatsuya Oda, Taira Kinoshita.   

Abstract

OBJECTIVES: The prognosis of pancreatic carcinoma is generally very poor and difficult to predict. The aim of this study was to quantitate prognosis with the onset symptoms.
METHODS: Survival curves and clinicopathological findings of 209 patients with pancreatic cancer admitted to our hospital between 1992 and 1998 were retrospectively analyzed with reference to their onset symptoms (eg, abdominal pain, back pain, jaundice, general fatigue, nausea) and tumor location (eg, head, body, tail). The interval from the onset symptoms to the patient's first medical treatment and laboratory data of the patients were also reviewed. Univariate and multivariate analyses were performed using Cox proportional hazards regression model.
RESULTS: The patients who had initially had jaundice had a significantly shorter interval between onset symptoms and first medical treatment and a significantly better prognosis than other patients. The patients who initially had back pain had a significantly poorer rate survival rate. Onset symptoms had a significant correlation with tumor location, which is a significant prognostic factor, but remained a significant prognostic factor with multivariate analysis.
CONCLUSIONS: The onset symptom of patients with pancreatic carcinoma closely correlates with prognosis.

Entities:  

Mesh:

Year:  2004        PMID: 15028948     DOI: 10.1097/00006676-200403000-00007

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  36 in total

1.  Diagnosing and managing pancreatic cancer.

Authors:  Matthew T Huggett; Stephen P Pereira
Journal:  Practitioner       Date:  2011 Jul-Aug

2.  Diagnostic utility of clinical and biochemical parameters in pancreatic head malignancy patients with normal carbohydrate antigen 19-9 levels.

Authors:  Xiaoli Jin; Yulian Wu
Journal:  Afr Health Sci       Date:  2015-03       Impact factor: 0.927

3.  Comparative bioinformatical analysis of pancreatic head cancer and pancreatic body/tail cancer.

Authors:  Lingdi Yin; Linmei Xiao; Yong Gao; Guangfu Wang; Hao Gao; Yunpeng Peng; Xiaole Zhu; Jishu Wei; Yi Miao; Kuirong Jiang; Zipeng Lu
Journal:  Med Oncol       Date:  2020-04-10       Impact factor: 3.064

4.  McGill Brisbane Symptom Score for patients with resectable pancreatic head adenocarcinoma.

Authors:  Mohammed H Jamal; Suhail A R Doi; A James Moser; Sinziana Dumitra; Jad abou Khalil; Eve Simoneau; Prosanto Chaudhury; Adedayo A Onitilo; Peter Metrakos; Jeffrey S Barkun
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

5.  Plasma protein profiling in a stage defined pancreatic cancer cohort - Implications for early diagnosis.

Authors:  Anna Sandström Gerdtsson; Christer Wingren; Helena Persson; Payam Delfani; Malin Nordström; He Ren; Xin Wen; Ulrika Ringdahl; Carl A K Borrebaeck; Jihui Hao
Journal:  Mol Oncol       Date:  2016-07-12       Impact factor: 6.603

6.  CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinoma.

Authors:  Gang Yang; Yicheng Wang; Jianchun Xiao; Fangyu Zhao; Jiangdong Qiu; Yueze Liu; Guangyu Chen; Zhe Cao; Lei You; Lianfang Zheng; Taiping Zhang; Yupei Zhao
Journal:  Cell Oncol (Dordr)       Date:  2020-10-30       Impact factor: 6.730

7.  The anatomic location of pancreatic cancer is a prognostic factor for survival.

Authors:  Avo Artinyan; Perry A Soriano; Christina Prendergast; Tracey Low; Joshua D I Ellenhorn; Joseph Kim
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

8.  Long-term results and prognostic factors in resected pancreatic body and tail adenocarcinomas.

Authors:  Vinayak S Rohan; Jun-Te Hsu; Keng-Hao Liu; Chun-Nan Yeh; Ta-Sen Yeh; Yi-Yin Jan; Tsann-Long Hwang
Journal:  J Gastrointest Cancer       Date:  2013-03

9.  Prognostic factors in patients with pancreatic cancer.

Authors:  DE-Xiang Zhang; Yue-DI Dai; Su-Xu Yuan; Li Tao
Journal:  Exp Ther Med       Date:  2011-12-08       Impact factor: 2.447

10.  Evaluation of DNA ploidy in relation with established prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.

Authors:  Nikolas Tsavaris; Nicolaos Kavantzas; Kostantinos Tsigritis; Ioannis D Xynos; Nikitas Papadoniou; Andreas Lazaris; Christos Kosmas; George Agrogiannis; Anna Dokou; Evangelos Felekouras; Efstathios Antoniou; Aris Polyzos; John Sarantonis; Heracles Tsipras; Gavrilos Karatzas; Alexandros Papalambros; Efstratios S Patsouris
Journal:  BMC Cancer       Date:  2009-07-31       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.